Cargando…

Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients

BACKGROUND: Given the inadequate control of pain in patients with the trauma that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr Isfahani, Mehdi, Shokoohi, Omid, Golshani, Keihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943598/
https://www.ncbi.nlm.nih.gov/pubmed/35342440
http://dx.doi.org/10.4103/jrms.JRMS_505_20
_version_ 1784673554256625664
author Nasr Isfahani, Mehdi
Shokoohi, Omid
Golshani, Keihan
author_facet Nasr Isfahani, Mehdi
Shokoohi, Omid
Golshani, Keihan
author_sort Nasr Isfahani, Mehdi
collection PubMed
description BACKGROUND: Given the inadequate control of pain in patients with the trauma that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients. MATERIALS AND METHODS: The current study was performed on 125 patients that were divided into the following three groups: control group (n = 41), 1 mg/kg intranasal ketamine group (n = 40), and 1 μg/kg intranasal fentanyl group (n = 44). Then pain scores, heart rate, respiratory rate, blood pressure, and oxygen saturation were recorded at baseline, 5, 10, 15, 30, and 40 min after the intervention. RESULTS: Visual analog scale (VAS) scores of patients in the intranasal ketamine group 5 and 10 min after the intervention were 61.50 ± 20.45 and 55.00 ± 21.96, respectively. The mentioned scores were significantly lower than the VAS scores of patients in the control group with the mean of 72.44 ± 22.11 and 66.59 ± 24.25 and the VAS scores of patients in the intranasal fentanyl group with the mean of 71.59 ± 22.09 and 65.00 ± 22.87 at 5 and 10 min after the intervention, respectively (P < 0.05). CONCLUSION: Given the onset of action in < 10 min, intranasal ketamine can be proposed as an appropriate analgesic medication in pain reduction of patients with isolated limb injuries. Moreover, the incidence rate and severity of adverse effects were insignificantly higher in the intranasal ketamine group as compared with the intranasal fentanyl group.
format Online
Article
Text
id pubmed-8943598
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89435982022-03-25 Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients Nasr Isfahani, Mehdi Shokoohi, Omid Golshani, Keihan J Res Med Sci Original Article BACKGROUND: Given the inadequate control of pain in patients with the trauma that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients. MATERIALS AND METHODS: The current study was performed on 125 patients that were divided into the following three groups: control group (n = 41), 1 mg/kg intranasal ketamine group (n = 40), and 1 μg/kg intranasal fentanyl group (n = 44). Then pain scores, heart rate, respiratory rate, blood pressure, and oxygen saturation were recorded at baseline, 5, 10, 15, 30, and 40 min after the intervention. RESULTS: Visual analog scale (VAS) scores of patients in the intranasal ketamine group 5 and 10 min after the intervention were 61.50 ± 20.45 and 55.00 ± 21.96, respectively. The mentioned scores were significantly lower than the VAS scores of patients in the control group with the mean of 72.44 ± 22.11 and 66.59 ± 24.25 and the VAS scores of patients in the intranasal fentanyl group with the mean of 71.59 ± 22.09 and 65.00 ± 22.87 at 5 and 10 min after the intervention, respectively (P < 0.05). CONCLUSION: Given the onset of action in < 10 min, intranasal ketamine can be proposed as an appropriate analgesic medication in pain reduction of patients with isolated limb injuries. Moreover, the incidence rate and severity of adverse effects were insignificantly higher in the intranasal ketamine group as compared with the intranasal fentanyl group. Wolters Kluwer - Medknow 2022-01-29 /pmc/articles/PMC8943598/ /pubmed/35342440 http://dx.doi.org/10.4103/jrms.JRMS_505_20 Text en Copyright: © 2022 Journal of Research in Medical Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Nasr Isfahani, Mehdi
Shokoohi, Omid
Golshani, Keihan
Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title_full Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title_fullStr Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title_full_unstemmed Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title_short Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
title_sort intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943598/
https://www.ncbi.nlm.nih.gov/pubmed/35342440
http://dx.doi.org/10.4103/jrms.JRMS_505_20
work_keys_str_mv AT nasrisfahanimehdi intranasalketamineversusintranasalfentanylonpainmanagementinisolatedtraumaticpatients
AT shokoohiomid intranasalketamineversusintranasalfentanylonpainmanagementinisolatedtraumaticpatients
AT golshanikeihan intranasalketamineversusintranasalfentanylonpainmanagementinisolatedtraumaticpatients